Cargando…

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers worldwide, mainly due to its late diagnosis and lack of effective therapies, translating into a low 5-year 12% survival rate, despite extensive clinical efforts to improve outcomes. International cooperative studies have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alors-Pérez, Emilia, Pedraza-Arevalo, Sergio, Blázquez-Encinas, Ricardo, Moreno-Montilla, María Trinidad, García-Vioque, Víctor, Berbel, Inmaculada, Luque, Raúl M., Sainz, Bruno, Ibáñez-Costa, Alejandro, Castaño, Justo P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601233/ https://www.ncbi.nlm.nih.gov/pubmed/37880792 http://dx.doi.org/10.1186/s13046-023-02858-z

Ejemplares similares

The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities
por: Blázquez-Encinas, Ricardo, et al.
Publicado: (2022)

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery
por: Blázquez-Encinas, Ricardo, et al.
Publicado: (2023)

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
por: Alors-Perez, Emilia, et al.
Publicado: (2021)

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
por: López‐Cánovas, Juan L., et al.
Publicado: (2022)

Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study
por: del Río-Moreno, Mercedes, et al.
Publicado: (2020)

Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018)

Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study
por: Gahete, Manuel D., et al.
Publicado: (2018)

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2020)

SUN-LB056 The Pharmacological Blockade of the Splicing Factor SF3B1 Exerts Antitumor Actions in Different Endocrine-Related Cancers
por: Gahete, Manuel, et al.
Publicado: (2019)

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2022)

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2021)

Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST(5)) in pituitary and pancreatic neuroendocrine tumors
por: Pedraza‐Arevalo, Sergio, et al.
Publicado: (2021)

Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2020)

Endocrine Oncology: the home for translational research in cancer and hormones
por: Castaño, Justo P
Publicado: (2023)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters
por: Luque, Raul M., et al.
Publicado: (2015)

Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2022)

The translational landscape of the splicing factor SRSF1 and its role in mitosis
por: Maslon, Magdalena M, et al.
Publicado: (2014)

Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2015)

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2015)

BRCA1 Alternative splicing landscape in breast tissue samples
por: Romero, Atocha, et al.
Publicado: (2015)

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
por: Hormaechea-Agulla, Daniel, et al.
Publicado: (2017)

Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma
por: Sanjuan-Sanjuan, Alba, et al.
Publicado: (2021)

Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017)

Landscape of the spliced leader trans-splicing mechanism in Schistosoma mansoni
por: Boroni, Mariana, et al.
Publicado: (2018)

THU080 Splicing Machinery Dysregulation As A Source Of Novel Diagnostic, Prognostic And Therapeutic Targets In Craniopharyngiomas
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2023)

The landscape of human mutually exclusive splicing
por: Hatje, Klas, et al.
Publicado: (2017)

Landscape of alternative splicing in Capra_hircus
por: Xu, Tieshan, et al.
Publicado: (2018)

Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
por: Bailey, Peter, et al.
Publicado: (2016)

Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma
por: Roy, Shikha, et al.
Publicado: (2021)

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2016)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

The Changing Landscape of Alopecia Areata: The Translational Landscape
por: Wang, Etienne C. E., et al.
Publicado: (2017)

Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
por: Supadmanaba, I Gede Putu, et al.
Publicado: (2021)

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
por: López-Cánovas, Juan L., et al.
Publicado: (2023)

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
por: Vázquez-Borrego, Mari C., et al.
Publicado: (2019)

Pre-mRNA Splicing in the Nuclear Landscape
por: Carrocci, Tucker J., et al.
Publicado: (2020)

Transcriptional Landscape and Splicing Efficiency in Arabidopsis Mitochondria
por: Garcia, Laura E., et al.
Publicado: (2021)

Complex Landscape of Alternative Splicing in Myeloid Neoplasms
por: Hershberger, Courtney E., et al.
Publicado: (2020)

Alternative splicing in shaping the molecular landscape of the cochlea
por: Kim, Kwan Soo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ncl5j8imjbvcddg595d4339igo